Claritev Corporation (CTEV) Reports Q3 Loss, Tops Revenue Estimates

分组1 - Claritev Corporation reported a quarterly loss of $4.07 per share, which was worse than the Zacks Consensus Estimate of a loss of $3.12, and compared to a loss of $1.85 per share a year ago, indicating a significant decline in performance [1] - The company posted revenues of $245.96 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 4.87% and showing an increase from $230.49 million in the same quarter last year [2] - Claritev Corporation's shares have increased approximately 319.2% since the beginning of the year, significantly outperforming the S&P 500's gain of 14.3% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$3.07 on revenues of $236.34 million, and for the current fiscal year, it is -$14.36 on revenues of $943.77 million [7] - The Medical Info Systems industry, to which Claritev Corporation belongs, is currently ranked in the top 28% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8]